Extranodal extension influences prognosis in pancreatic body/tail cancer: A retrospective cohort study

Background/Purpose Extranodal extension (ENE) is an established prognostic factor in various malignancies, affecting survival in pancreatic head cancer (PHC). However, its significance in pancreatic body/tail cancer (PBTC) remains unclear. Therefore, we aimed to investigate the impact of ENE on PTBC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepato-biliary-pancreatic sciences 2024-08, Vol.31 (8), p.569-580
Hauptverfasser: Sung, Min Kyu, Chun, Jihyun, Park, Yejong, Kwak, Bong Jun, Lee, Woohyung, Song, Ki Byung, Lee, Jae Hoon, Kim, Song Cheol, Hong, Seung Mo, Hwang, Dae Wook
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 580
container_issue 8
container_start_page 569
container_title Journal of hepato-biliary-pancreatic sciences
container_volume 31
creator Sung, Min Kyu
Chun, Jihyun
Park, Yejong
Kwak, Bong Jun
Lee, Woohyung
Song, Ki Byung
Lee, Jae Hoon
Kim, Song Cheol
Hong, Seung Mo
Hwang, Dae Wook
description Background/Purpose Extranodal extension (ENE) is an established prognostic factor in various malignancies, affecting survival in pancreatic head cancer (PHC). However, its significance in pancreatic body/tail cancer (PBTC) remains unclear. Therefore, we aimed to investigate the impact of ENE on PTBC prognosis. Methods We analyzed data collected from electronic medical records of patients with PBTC who underwent distal pancreatectomy at a single center between January 2011 and December 2015. The patients were categorized based on ENE presence and prognostic implications were evaluated using Kaplan–Meier survival curves and Cox proportional hazards model. Results PBTC cases involving lymph node (LN) metastasis and ENE exhibited significantly lower disease‐free (DFS) and overall survival (OS) rates compared to cases without LN metastasis or ENE (median DFS; N0, 23 months; LN+/ENE−, 10 months; LN+/ENE+, 5 months; p 
doi_str_mv 10.1002/jhbp.12008
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11503450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3096434797</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3388-1a4e329c3f5ba2b96da3ee8e30fac71eafde16a9c5f69908842c64d23db604813</originalsourceid><addsrcrecordid>eNp9kUFrGzEQhUVpaILjS39AEeRSAk6k1Vor5RIck8QpgfbQnoVWOxvLrKWtpHXjf18lTkyaQwWDxMzH440eQp8pOaOEFOerZd2f0YIQ8QEdUcHFhEtRfNy_q_IQjWNckXwYZZKRT-iQCVGxqhBHqL1-TEE73-gOw2MCF6132Lq2G8AZiLgP_sH5aGNu4l47E0Ana3Dtm-150rbDJjchXOAZDpCCjz2YZDeAjV_6kHBMQ7M9Rget7iKMX-4R-nVz_XO-mNx_v72bz-4nhmVPE6pLYIU0rJ3WuqglbzQDEMBIq01FQbcNUK6lmbZcSiJEWRheNgVrak5KQdkIXe50-6FeQ2PA5e061Qe71mGrvLbq34mzS_XgN4rSKWFlrhH6-qIQ_O8BYlJrGw10nXbgh6gY4aKaCkFYRk_eoSs_BJf3y5TkJSsrWWXqdEeZ_DcxQLt3Q4l6ilA9RaieI8zwl7f-9-hrYBmgO-CP7WD7Hyn1bXH1Yyf6F70kqP0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3096434797</pqid></control><display><type>article</type><title>Extranodal extension influences prognosis in pancreatic body/tail cancer: A retrospective cohort study</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Sung, Min Kyu ; Chun, Jihyun ; Park, Yejong ; Kwak, Bong Jun ; Lee, Woohyung ; Song, Ki Byung ; Lee, Jae Hoon ; Kim, Song Cheol ; Hong, Seung Mo ; Hwang, Dae Wook</creator><creatorcontrib>Sung, Min Kyu ; Chun, Jihyun ; Park, Yejong ; Kwak, Bong Jun ; Lee, Woohyung ; Song, Ki Byung ; Lee, Jae Hoon ; Kim, Song Cheol ; Hong, Seung Mo ; Hwang, Dae Wook</creatorcontrib><description>Background/Purpose Extranodal extension (ENE) is an established prognostic factor in various malignancies, affecting survival in pancreatic head cancer (PHC). However, its significance in pancreatic body/tail cancer (PBTC) remains unclear. Therefore, we aimed to investigate the impact of ENE on PTBC prognosis. Methods We analyzed data collected from electronic medical records of patients with PBTC who underwent distal pancreatectomy at a single center between January 2011 and December 2015. The patients were categorized based on ENE presence and prognostic implications were evaluated using Kaplan–Meier survival curves and Cox proportional hazards model. Results PBTC cases involving lymph node (LN) metastasis and ENE exhibited significantly lower disease‐free (DFS) and overall survival (OS) rates compared to cases without LN metastasis or ENE (median DFS; N0, 23 months; LN+/ENE−, 10 months; LN+/ENE+, 5 months; p &lt; .001). No statistically significant difference was observed in DFS and OS rates between patients with N1/N2 in the group without ENE and those with ENE+. Multivariate analysis confirmed ENE as a significant adverse prognostic factor. Conclusions ENE significantly predicts poor prognosis in PBTC, particularly in cases with nodal metastasis. The current cancer staging system for PBTC should incorporate ENE status. Moreover, different staging systems should be considered for PHC and PBTC. Sung and colleagues identified extranodal extension as a significant adverse prognostic factor in patients with pancreatic body/tail cancer, concluding that extranodal extension should be incorporated into the current staging system. Additionally, the differences observed in subgroup analysis between pancreatic head and body/tail cancer suggest the necessity of separate staging systems.</description><identifier>ISSN: 1868-6974</identifier><identifier>ISSN: 1868-6982</identifier><identifier>EISSN: 1868-6982</identifier><identifier>DOI: 10.1002/jhbp.12008</identifier><identifier>PMID: 38873728</identifier><language>eng</language><publisher>Japan: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Cancer ; Disease-Free Survival ; extranodal extension ; Extranodal Extension - pathology ; Female ; Humans ; Lymphatic Metastasis ; Male ; Medical prognosis ; Metastasis ; Middle Aged ; Neoplasm Staging ; Original ; Pancreatectomy ; pancreatic cancer ; Pancreatic Neoplasms - mortality ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - surgery ; Prognosis ; Retrospective Studies ; survival ; Survival Rate ; TNM staging system</subject><ispartof>Journal of hepato-biliary-pancreatic sciences, 2024-08, Vol.31 (8), p.569-580</ispartof><rights>2024 The Author(s). published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.</rights><rights>2024 The Author(s). Journal of Hepato‐Biliary‐Pancreatic Sciences published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3388-1a4e329c3f5ba2b96da3ee8e30fac71eafde16a9c5f69908842c64d23db604813</cites><orcidid>0000-0002-8119-6943 ; 0000-0001-5422-5481 ; 0000-0002-1749-038X ; 0000-0001-8532-9531</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjhbp.12008$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjhbp.12008$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38873728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sung, Min Kyu</creatorcontrib><creatorcontrib>Chun, Jihyun</creatorcontrib><creatorcontrib>Park, Yejong</creatorcontrib><creatorcontrib>Kwak, Bong Jun</creatorcontrib><creatorcontrib>Lee, Woohyung</creatorcontrib><creatorcontrib>Song, Ki Byung</creatorcontrib><creatorcontrib>Lee, Jae Hoon</creatorcontrib><creatorcontrib>Kim, Song Cheol</creatorcontrib><creatorcontrib>Hong, Seung Mo</creatorcontrib><creatorcontrib>Hwang, Dae Wook</creatorcontrib><title>Extranodal extension influences prognosis in pancreatic body/tail cancer: A retrospective cohort study</title><title>Journal of hepato-biliary-pancreatic sciences</title><addtitle>J Hepatobiliary Pancreat Sci</addtitle><description>Background/Purpose Extranodal extension (ENE) is an established prognostic factor in various malignancies, affecting survival in pancreatic head cancer (PHC). However, its significance in pancreatic body/tail cancer (PBTC) remains unclear. Therefore, we aimed to investigate the impact of ENE on PTBC prognosis. Methods We analyzed data collected from electronic medical records of patients with PBTC who underwent distal pancreatectomy at a single center between January 2011 and December 2015. The patients were categorized based on ENE presence and prognostic implications were evaluated using Kaplan–Meier survival curves and Cox proportional hazards model. Results PBTC cases involving lymph node (LN) metastasis and ENE exhibited significantly lower disease‐free (DFS) and overall survival (OS) rates compared to cases without LN metastasis or ENE (median DFS; N0, 23 months; LN+/ENE−, 10 months; LN+/ENE+, 5 months; p &lt; .001). No statistically significant difference was observed in DFS and OS rates between patients with N1/N2 in the group without ENE and those with ENE+. Multivariate analysis confirmed ENE as a significant adverse prognostic factor. Conclusions ENE significantly predicts poor prognosis in PBTC, particularly in cases with nodal metastasis. The current cancer staging system for PBTC should incorporate ENE status. Moreover, different staging systems should be considered for PHC and PBTC. Sung and colleagues identified extranodal extension as a significant adverse prognostic factor in patients with pancreatic body/tail cancer, concluding that extranodal extension should be incorporated into the current staging system. Additionally, the differences observed in subgroup analysis between pancreatic head and body/tail cancer suggest the necessity of separate staging systems.</description><subject>Adult</subject><subject>Aged</subject><subject>Cancer</subject><subject>Disease-Free Survival</subject><subject>extranodal extension</subject><subject>Extranodal Extension - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Original</subject><subject>Pancreatectomy</subject><subject>pancreatic cancer</subject><subject>Pancreatic Neoplasms - mortality</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - surgery</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>survival</subject><subject>Survival Rate</subject><subject>TNM staging system</subject><issn>1868-6974</issn><issn>1868-6982</issn><issn>1868-6982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp9kUFrGzEQhUVpaILjS39AEeRSAk6k1Vor5RIck8QpgfbQnoVWOxvLrKWtpHXjf18lTkyaQwWDxMzH440eQp8pOaOEFOerZd2f0YIQ8QEdUcHFhEtRfNy_q_IQjWNckXwYZZKRT-iQCVGxqhBHqL1-TEE73-gOw2MCF6132Lq2G8AZiLgP_sH5aGNu4l47E0Ana3Dtm-150rbDJjchXOAZDpCCjz2YZDeAjV_6kHBMQ7M9Rget7iKMX-4R-nVz_XO-mNx_v72bz-4nhmVPE6pLYIU0rJ3WuqglbzQDEMBIq01FQbcNUK6lmbZcSiJEWRheNgVrak5KQdkIXe50-6FeQ2PA5e061Qe71mGrvLbq34mzS_XgN4rSKWFlrhH6-qIQ_O8BYlJrGw10nXbgh6gY4aKaCkFYRk_eoSs_BJf3y5TkJSsrWWXqdEeZ_DcxQLt3Q4l6ilA9RaieI8zwl7f-9-hrYBmgO-CP7WD7Hyn1bXH1Yyf6F70kqP0</recordid><startdate>202408</startdate><enddate>202408</enddate><creator>Sung, Min Kyu</creator><creator>Chun, Jihyun</creator><creator>Park, Yejong</creator><creator>Kwak, Bong Jun</creator><creator>Lee, Woohyung</creator><creator>Song, Ki Byung</creator><creator>Lee, Jae Hoon</creator><creator>Kim, Song Cheol</creator><creator>Hong, Seung Mo</creator><creator>Hwang, Dae Wook</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8119-6943</orcidid><orcidid>https://orcid.org/0000-0001-5422-5481</orcidid><orcidid>https://orcid.org/0000-0002-1749-038X</orcidid><orcidid>https://orcid.org/0000-0001-8532-9531</orcidid></search><sort><creationdate>202408</creationdate><title>Extranodal extension influences prognosis in pancreatic body/tail cancer: A retrospective cohort study</title><author>Sung, Min Kyu ; Chun, Jihyun ; Park, Yejong ; Kwak, Bong Jun ; Lee, Woohyung ; Song, Ki Byung ; Lee, Jae Hoon ; Kim, Song Cheol ; Hong, Seung Mo ; Hwang, Dae Wook</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3388-1a4e329c3f5ba2b96da3ee8e30fac71eafde16a9c5f69908842c64d23db604813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cancer</topic><topic>Disease-Free Survival</topic><topic>extranodal extension</topic><topic>Extranodal Extension - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Original</topic><topic>Pancreatectomy</topic><topic>pancreatic cancer</topic><topic>Pancreatic Neoplasms - mortality</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - surgery</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>survival</topic><topic>Survival Rate</topic><topic>TNM staging system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sung, Min Kyu</creatorcontrib><creatorcontrib>Chun, Jihyun</creatorcontrib><creatorcontrib>Park, Yejong</creatorcontrib><creatorcontrib>Kwak, Bong Jun</creatorcontrib><creatorcontrib>Lee, Woohyung</creatorcontrib><creatorcontrib>Song, Ki Byung</creatorcontrib><creatorcontrib>Lee, Jae Hoon</creatorcontrib><creatorcontrib>Kim, Song Cheol</creatorcontrib><creatorcontrib>Hong, Seung Mo</creatorcontrib><creatorcontrib>Hwang, Dae Wook</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sung, Min Kyu</au><au>Chun, Jihyun</au><au>Park, Yejong</au><au>Kwak, Bong Jun</au><au>Lee, Woohyung</au><au>Song, Ki Byung</au><au>Lee, Jae Hoon</au><au>Kim, Song Cheol</au><au>Hong, Seung Mo</au><au>Hwang, Dae Wook</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extranodal extension influences prognosis in pancreatic body/tail cancer: A retrospective cohort study</atitle><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle><addtitle>J Hepatobiliary Pancreat Sci</addtitle><date>2024-08</date><risdate>2024</risdate><volume>31</volume><issue>8</issue><spage>569</spage><epage>580</epage><pages>569-580</pages><issn>1868-6974</issn><issn>1868-6982</issn><eissn>1868-6982</eissn><abstract>Background/Purpose Extranodal extension (ENE) is an established prognostic factor in various malignancies, affecting survival in pancreatic head cancer (PHC). However, its significance in pancreatic body/tail cancer (PBTC) remains unclear. Therefore, we aimed to investigate the impact of ENE on PTBC prognosis. Methods We analyzed data collected from electronic medical records of patients with PBTC who underwent distal pancreatectomy at a single center between January 2011 and December 2015. The patients were categorized based on ENE presence and prognostic implications were evaluated using Kaplan–Meier survival curves and Cox proportional hazards model. Results PBTC cases involving lymph node (LN) metastasis and ENE exhibited significantly lower disease‐free (DFS) and overall survival (OS) rates compared to cases without LN metastasis or ENE (median DFS; N0, 23 months; LN+/ENE−, 10 months; LN+/ENE+, 5 months; p &lt; .001). No statistically significant difference was observed in DFS and OS rates between patients with N1/N2 in the group without ENE and those with ENE+. Multivariate analysis confirmed ENE as a significant adverse prognostic factor. Conclusions ENE significantly predicts poor prognosis in PBTC, particularly in cases with nodal metastasis. The current cancer staging system for PBTC should incorporate ENE status. Moreover, different staging systems should be considered for PHC and PBTC. Sung and colleagues identified extranodal extension as a significant adverse prognostic factor in patients with pancreatic body/tail cancer, concluding that extranodal extension should be incorporated into the current staging system. Additionally, the differences observed in subgroup analysis between pancreatic head and body/tail cancer suggest the necessity of separate staging systems.</abstract><cop>Japan</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38873728</pmid><doi>10.1002/jhbp.12008</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-8119-6943</orcidid><orcidid>https://orcid.org/0000-0001-5422-5481</orcidid><orcidid>https://orcid.org/0000-0002-1749-038X</orcidid><orcidid>https://orcid.org/0000-0001-8532-9531</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1868-6974
ispartof Journal of hepato-biliary-pancreatic sciences, 2024-08, Vol.31 (8), p.569-580
issn 1868-6974
1868-6982
1868-6982
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11503450
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Aged
Cancer
Disease-Free Survival
extranodal extension
Extranodal Extension - pathology
Female
Humans
Lymphatic Metastasis
Male
Medical prognosis
Metastasis
Middle Aged
Neoplasm Staging
Original
Pancreatectomy
pancreatic cancer
Pancreatic Neoplasms - mortality
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - surgery
Prognosis
Retrospective Studies
survival
Survival Rate
TNM staging system
title Extranodal extension influences prognosis in pancreatic body/tail cancer: A retrospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T06%3A10%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extranodal%20extension%20influences%20prognosis%20in%20pancreatic%20body/tail%20cancer:%20A%20retrospective%20cohort%20study&rft.jtitle=Journal%20of%20hepato-biliary-pancreatic%20sciences&rft.au=Sung,%20Min%20Kyu&rft.date=2024-08&rft.volume=31&rft.issue=8&rft.spage=569&rft.epage=580&rft.pages=569-580&rft.issn=1868-6974&rft.eissn=1868-6982&rft_id=info:doi/10.1002/jhbp.12008&rft_dat=%3Cproquest_pubme%3E3096434797%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3096434797&rft_id=info:pmid/38873728&rfr_iscdi=true